CVH-HCC patients with peritumoral LINC00635 expression had shorter mean OS [79.97 ± 11.98 (95% CI 56.49-103.45) vs. 112.73 ± 12.60 months (95% CI 88.03-137.44), p=0.11]. This evidence concerns the gene LINC00635 and hepatocellular carcinoma.